Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Analysis
Free AI-powered analysis and research for Arrowhead Pharmaceuticals, Inc. stock
Sector: Healthcare
Analyze Arrowhead Pharmaceuticals, Inc. (ARWR) Stock
Arrowhead Pharmaceuticals, Inc. (ARWR) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into ARWR stock performance, technical indicators, and AI-powered trading recommendations.
Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Arrowhead Pharmaceuticals, Inc. stock.
Analyze ARWR Now βπ° Latest Update
ARWR Stock Clocks Best Day In Nearly 8 Months As Analyst Lifts Price Target On Plozasiran Data
Wed, July 22, 2026 at 10:44 PM UTC 4 min read
ARWR shares experienced their best performance in nearly eight months following an analyst's upgrade of the price target based on promising data for Plozasiran, a treatment for alpha-1 antitrypsin deficiency. This positive sentiment reflects growing confidence in the company's pipeline, which could enhance its market position and attract investor interest. The upgrade may signal potential for further gains as clinical developments progress.
History
π Technical Analysis
RSI, MACD, moving averages, support/resistance levels, and momentum indicators for Arrowhead Pharmaceuticals, Inc. (ARWR) stock.
π€ AI Insights
AI-powered analysis of Arrowhead Pharmaceuticals, Inc. (ARWR) fundamentals, growth prospects, and market position.
β οΈ Risk Assessment
Comprehensive risk analysis including volatility, sector risks, and market conditions for Arrowhead Pharmaceuticals, Inc. stock.
Why Analyze Arrowhead Pharmaceuticals, Inc. (ARWR) with StockIQ?
- β Free AI-powered analysis of Arrowhead Pharmaceuticals, Inc. (ARWR) stock
- β Real-time technical indicators for Arrowhead Pharmaceuticals, Inc. stock
- β Comprehensive risk assessment for ARWR
- β No credit card required